Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death
- PMID: 15705901
Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death
Abstract
Active Ras and phosphatidylinositol-3-kinase-dependent pathways contribute to the malignant phenotype of glioblastoma multiformes (GBM). Here we show that the Ras inhibitor trans-farnesylthiosalicylic acid (FTS) exhibits profound antioncogenic effects in U87 GBM cells. FTS inhibited active Ras and attenuated Ras signaling to extracellular signal-regulated kinase, phosphatidylinositol-3-kinase, and Akt. Concomitantly, hypoxia-inducible factor 1alpha (HIF-1alpha) disappeared, expression of key glycolysis pathway enzymes and of other HIF-1alpha-regulated genes (including vascular endothelial growth factor and the Glut-1 glucose transporter) was down-regulated, and glycolysis was halted. This led to a dramatic reduction in ATP, resulting in a severe energy crisis. In addition, the expression of E2F-regulated genes was down-regulated in the FTS-treated cells. Consequently, U87 cell growth was arrested and the cells died. These results show that FTS is a potent down-regulator of HIF-1alpha and might therefore block invasiveness, survival, and angiogenesis in GBM.
Similar articles
-
Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).Cancer Res. 2007 Apr 1;67(7):3320-8. doi: 10.1158/0008-5472.CAN-06-4287. Cancer Res. 2007. PMID: 17409441
-
The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.Clin Cancer Res. 2006 Sep 15;12(18):5533-42. doi: 10.1158/1078-0432.CCR-06-0792. Clin Cancer Res. 2006. PMID: 17000690
-
A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.Cancer Res. 2005 Aug 15;65(16):7267-75. doi: 10.1158/0008-5472.CAN-04-4575. Cancer Res. 2005. PMID: 16103078
-
Advances in the targeting of HIF-1α and future therapeutic strategies for glioblastoma multiforme (Review).Oncol Rep. 2017 Feb;37(2):657-670. doi: 10.3892/or.2016.5309. Epub 2016 Dec 9. Oncol Rep. 2017. PMID: 27959421 Review.
-
Role of AHR and HIF-1α in Glioblastoma Metabolism.Trends Endocrinol Metab. 2017 Jun;28(6):428-436. doi: 10.1016/j.tem.2017.02.009. Epub 2017 Mar 16. Trends Endocrinol Metab. 2017. PMID: 28318896 Free PMC article. Review.
Cited by
-
Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model.Mol Biol Rep. 2020 Oct;47(10):7783-7795. doi: 10.1007/s11033-020-05855-z. Epub 2020 Sep 27. Mol Biol Rep. 2020. PMID: 32981013 Free PMC article.
-
Characteristic Mutational Damages in Gastric and Colorectal Adenocarcinomas.Asian Pac J Cancer Prev. 2023 Nov 1;24(11):3939-3947. doi: 10.31557/APJCP.2023.24.11.3939. Asian Pac J Cancer Prev. 2023. PMID: 38019254 Free PMC article.
-
Exploiting metabolic differences in glioma therapy.Curr Drug Discov Technol. 2012 Dec;9(4):280-93. doi: 10.2174/157016312803305906. Curr Drug Discov Technol. 2012. PMID: 22339075 Free PMC article. Review.
-
Secreted Glioblastoma Nanovesicles Contain Intracellular Signaling Proteins and Active Ras Incorporated in a Farnesylation-dependent Manner.J Biol Chem. 2017 Jan 13;292(2):611-628. doi: 10.1074/jbc.M116.747618. Epub 2016 Dec 1. J Biol Chem. 2017. PMID: 27909058 Free PMC article.
-
Interplay Between HGF/SF-Met-Ras Signaling, Tumor Metabolism and Blood Flow as a Potential Target for Breast Cancer Therapy.Oncoscience. 2013 Dec 11;1(1):30-38. doi: 10.18632/oncoscience.6. eCollection 2014. Oncoscience. 2013. PMID: 25593982 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous